{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/ibandronate",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972306",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972306_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aceclofenac\" outputclass=\"int-drug\">Aceclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aceclofenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aceclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972307",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972307_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"amikacin\" outputclass=\"int-drug\">Amikacin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Amikacin   increases   the risk of hypocalcaemia when given with   ibandronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amikacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972308",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972308_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">are predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid antacids for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   are predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid antacids for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Antacids</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972309",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972309_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aspirin\" outputclass=\"int-drug\">Aspirin</ph> <ph outputclass=\"int-substanceQualifier\">(high-dose)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aspirin   (high-dose)   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aspirin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972310",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972310_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"benzydamine\" outputclass=\"int-drug\">Benzydamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Benzydamine   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Benzydamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972311",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972311_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"bromfenac\" outputclass=\"int-drug\">Bromfenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Bromfenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bromfenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972312",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972312_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\">calcium acetate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104228\">calcium acetate</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium acetate   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium acetate  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium acetate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972313",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972313_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\">calcium carbonate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-carbonate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93602\">calcium carbonate</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium carbonate   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium carbonate  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972314",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972314_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\">calcium chloride</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-chloride.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93603\">calcium chloride</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium chloride   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium chloride  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium chloride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972315",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972315_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\">calcium gluconate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-gluconate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93600\">calcium gluconate</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium gluconate   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium gluconate  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium gluconate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972316",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972316_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\">calcium lactate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-lactate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93601\">calcium lactate</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium lactate   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium lactate  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium lactate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972317",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972317_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\">calcium phosphate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-phosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP107980\">calcium phosphate</xref></ph> for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium phosphate   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  calcium phosphate  for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium phosphate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972318",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972318_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"celecoxib\" outputclass=\"int-drug\">Celecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Celecoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972319",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972319_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">Ibandronate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal bleeding when given with</ph> <ph otherprops=\"deferasirox\" outputclass=\"int-drug\">deferasirox</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ibandronate   is predicted to   increase   the risk of gastrointestinal bleeding when given with   deferasirox .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deferasirox</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972320",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972320_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"dexketoprofen\" outputclass=\"int-drug\">Dexketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Dexketoprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972321",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972321_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"diclofenac\" outputclass=\"int-drug\">Diclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Diclofenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972322",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972322_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"etodolac\" outputclass=\"int-drug\">Etodolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Etodolac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etodolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972323",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972323_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"etoricoxib\" outputclass=\"int-drug\">Etoricoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Etoricoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etoricoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972324",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972324_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"felbinac\" outputclass=\"int-drug\">Felbinac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Felbinac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felbinac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972325",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972325_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"flurbiprofen\" outputclass=\"int-drug\">Flurbiprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Flurbiprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flurbiprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972326",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972326_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"gentamicin\" outputclass=\"int-drug\">Gentamicin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Gentamicin   increases   the risk of hypocalcaemia when given with   ibandronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gentamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972327",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972327_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ibuprofen\" outputclass=\"int-drug\">Ibuprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ibuprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibuprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972328",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972328_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"indometacin\" outputclass=\"int-drug\">Indometacin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Indometacin   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indometacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972329",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972329_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"iron\" outputclass=\"int-drug\">iron</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph> should be taken 1 hour before or 6 hours after iron</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   iron   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises  ibandronate  should be taken 1 hour before or 6 hours after iron .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Iron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972330",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972330_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ketoprofen\" outputclass=\"int-drug\">Ketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ketoprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972331",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972331_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ketorolac\" outputclass=\"int-drug\">Ketorolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ketorolac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketorolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972332",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972332_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972333",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972333_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"mefenamic acid\" outputclass=\"int-drug\">Mefenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Mefenamic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mefenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972334",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972334_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"meloxicam\" outputclass=\"int-drug\">Meloxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Meloxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Meloxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972335",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972335_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nabumetone\" outputclass=\"int-drug\">Nabumetone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nabumetone   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nabumetone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972336",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972336_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"naproxen\" outputclass=\"int-drug\">Naproxen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Naproxen   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Naproxen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972337",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972337_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nepafenac\" outputclass=\"int-drug\">Nepafenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nepafenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nepafenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972338",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972338_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">Ibandronate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"parathyroid hormone\" outputclass=\"int-drug\">parathyroid hormone</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ibandronate   is predicted to   decrease   the effects of   parathyroid hormone .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parathyroid hormone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972339",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972339_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"parecoxib\" outputclass=\"int-drug\">Parecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Parecoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972340",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972340_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"phenazone\" outputclass=\"int-drug\">Phenazone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Phenazone   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenazone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972341",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972341_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"piroxicam\" outputclass=\"int-drug\">Piroxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Piroxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Piroxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972342",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972342_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"streptomycin\" outputclass=\"int-drug\">Streptomycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Streptomycin   increases   the risk of hypocalcaemia when given with   ibandronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972343",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972343_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulindac\" outputclass=\"int-drug\">Sulindac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulindac   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulindac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972344",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972344_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tenoxicam\" outputclass=\"int-drug\">Tenoxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tenoxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tenoxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972345",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972345_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tiaprofenic acid\" outputclass=\"int-drug\">Tiaprofenic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tiaprofenic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tiaprofenic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972346",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972346_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tobramycin\" outputclass=\"int-drug\">Tobramycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tobramycin   increases   the risk of hypocalcaemia when given with   ibandronate .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tobramycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972347",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972347_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tolfenamic acid\" outputclass=\"int-drug\">Tolfenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution and monitor adverse effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tolfenamic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   ibandronate .  Manufacturer advises caution and monitor adverse effects .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolfenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972348",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/ibandronate#bnf_i1643857972348_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\">ibandronate</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> (<ph otherprops=\"zinc acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6306\">zinc acetate</xref></ph>, <ph otherprops=\"zinc sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6172\">zinc sulfate</xref></ph>) for at least 6 hours before or 1 hour after <ph otherprops=\"ibandronate\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/ibandronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4671\">ibandronate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   zinc   is predicted to   decrease   the absorption of   oral   ibandronate .  Manufacturer advises avoid  zinc  ( zinc acetate ,  zinc sulfate ) for at least 6 hours before or 1 hour after  ibandronate .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zinc</title>"
					}
				}
			],
			"hasSearchLabel": " Ibandronate  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/ibandronate.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Ibandronate </title>"
			},
			"rdfs:label": "ibandronate"
		}
	]
}